prednisolone has been researched along with Neuroendocrine Tumors in 3 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Neuroendocrine Tumors: Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moore, AR | 1 |
| Chu, C | 1 |
| Singh, K | 1 |
| Barger, AM | 1 |
| Schnelle, AN | 1 |
| Lee, Y | 1 |
| Jung, HS | 1 |
| Choi, HJ | 1 |
| Kim, MJ | 1 |
| Kim, TM | 1 |
| Park, KS | 1 |
| Kim, SY | 1 |
| Freeman, HJ | 1 |
| Kwan, PW | 1 |
| Webber, D | 1 |
3 other studies available for prednisolone and Neuroendocrine Tumors
| Article | Year |
|---|---|
What is your diagnosis? Liver aspirate from a hypoglycemic dog.
Topics: Abdomen; Animals; Anticonvulsants; Biopsy, Fine-Needle; Dog Diseases; Dogs; Euthanasia, Animal; Hypo | 2015 |
Life-threatening hypoglycemia induced by a tyrosine kinase inhibitor in a patient with neuroendocrine tumor: a case report.
Topics: Adult; Antineoplastic Agents; Critical Care; Critical Illness; Humans; Hypoglycemia; Indoles; Male; | 2011 |
Large-cell neuroendocrine cancer of the colon following rituximab-based lymphoma treatment.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2012 |